ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.270
Day Range
$3.060 - $3.300
52 Week Range
$0.560 - $5.240
Volume
0.00
Avg Volume (10D)
633.32K
Market Cap
$516.93M
Price Chart
Market Statistics
Open$3.270
Previous Close$3.270
Day High$3.300
Day Low$3.060
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap516.93M
Shares Outstanding158.08M
Price to Book17.41
Trading Activity
Volume0.00
Value Traded0.00
Bid$3.400 × 1,000
Ask$3.300 × 1,000
Performance
1 Day-3.25%
5 Day-7.37%
13 Week-3.25%
52 Week311.32%
YTD-30.57%
Technical Indicators
RSI (14)32.27
50-Day SMA$3.955
200-Day SMA$2.263
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
